Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors

NCT02966691 is registered in ClinicalTrials.gov with Vitadx as lead sponsor.

NCT NCT02966691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02966691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors
Lead sponsor
Vitadx
Phase
Not applicable
Overall status
Completed
Start date
January 24, 2017
Completion date
January 16, 2021
Enrollment
1,360 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer